RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Bernard Arulanandam to Drug Resistance, Multiple, Bacterial

Back to Details
This is a "connection" page, showing publications Bernard Arulanandam has written about Drug Resistance, Multiple, Bacterial.
Bernard Arulanandam
Connection Strength
0.039
Drug Resistance, Multiple, Bacterial
  1. Holloway AJ, Yu J, Arulanandam BP, Hoskinson SM, Eaves-Pyles T. Cystatins 9 and C as a Novel Immunotherapy Treatment That Protects against Multidrug-Resistant New Delhi Metallo-Beta-Lactamase-1-Producing Klebsiella pneumoniae. Antimicrob Agents Chemother. 2018 03; 62(3).
    View in: PubMed
    Score: 0.039
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support